No abstract available
Publication types
-
Comparative Study
-
Controlled Clinical Trial
MeSH terms
-
Anilides / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents, Immunological / therapeutic use
-
Carcinoma, Basal Cell / drug therapy*
-
Carcinoma, Basal Cell / mortality*
-
Carcinoma, Basal Cell / pathology
-
Disease-Free Survival
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Humans
-
Infusions, Intravenous
-
Male
-
Neoplasm Invasiveness / pathology
-
Neoplasm Staging
-
Prognosis
-
Prospective Studies
-
Pyridines / therapeutic use*
-
Risk Assessment
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / mortality*
-
Skin Neoplasms / pathology
-
Survival Analysis
-
Treatment Outcome
Substances
-
Anilides
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
HhAntag691
-
Pyridines
-
pembrolizumab